ACRS stock news
This page provides real-time market news, earnings updates, and company announcements related to Aclaris Therapeutics, Inc. (ACRS).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-19 04:25 EST
Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer
Finviz2026-03-12 11:33:46
Aclaris Therapeutics Completes Enrollment in Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis
Finviz2026-03-18 10:58:03
Aclaris Therapeutics to Participate in the H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference
Finviz2026-04-08 12:33:10
Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth
Finviz2026-04-09 20:06:07
ACRS stock chart
ACRS stock detailsACRS stock price change
On the last trading day, ACRS stock closed at 4.25 USD, with a price change of 6.78% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more